Tag: diabetes diagnostics market share

  • Diabetes Diagnostics Market Expected To Reach $38.98 Billion By 2030 As Growth Accelerates At 7.3% CAGR

    Diabetes Diagnostics Market Expected To Reach $38.98 Billion By 2030 As Growth Accelerates At 7.3% CAGR

    Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

    Diabetes Diagnostics Market Value Analysis: What Growth Is Expected Over The Forecast Period?

    The market for diabetes diagnostic tools has experienced robust expansion recently, with projections indicating continued growth from $27.31 billion in 2025 to $29.39 billion in 2026, reflecting a compound annual growth rate of 7.6%. This upward trend in the past has been fueled by several factors, including the increasing incidence of diabetes worldwide, a continued dependence on fingerstick methods for blood glucose measurement, the expansion of diagnostic services within hospital settings, a heightened emphasis on managing glycemic levels, and the broader development of diagnostic laboratory infrastructure.

    The realm of diabetes diagnostics is poised for substantial expansion over the forthcoming years, with projections indicating a market valuation reaching $38.98 billion by the year 2030. This impressive growth trajectory is underpinned by a compound annual growth rate (CAGR) of 7.3%. Several key drivers are expected to fuel this upward trend, including the escalating utilization of continuous glucose monitoring systems, a growing preference for at-home diagnostic solutions, significant strides in biosensor technology, escalating global healthcare expenditures, and the broadening landscape of digital health solutions. Prominent developments anticipated within this period encompass the increased adoption of continuous glucose monitoring, the seamless integration of intelligent and networked diagnostic devices, a heightened demand for self-administered diabetes testing options, a greater emphasis on proactive diabetes detection initiatives, and ongoing innovations in non-invasive glucose monitoring techniques.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=21167&type=smp

    #Diabetes Diagnostics Market Growth Drivers And Industry Catalysts

    Anticipated increases in the rate of obesity are poised to be a significant catalyst for the expansion of the diabetes diagnostics sector

    Diabetes Diagnostics Market Segment Outlook: Which Categories Are Expanding The Fastest?

    The diabetes diagnostics market covered in this report is segmented –

    1) By Product Type: Blood Glucose Meters, Continuous Glucose Monitoring Devices, Lancets, Test Strips, Other Product Types

    2) By Diabetes Type: Diabetes I, Diabetes Ii, Gestational Diabetes

    3) By End-User: Hospitals, Diagnostic Centers, Homecare Settings, Other End-Users

    Subsegments:

    1) By Blood Glucose Meters: Traditional Blood Glucose Meters, Smart Blood Glucose Meters, Bluetooth-Enabled Blood Glucose Meters

    2) By Continuous Glucose Monitoring Devices: Wearable CGM Systems, Implantable CGM Systems, Flash Glucose Monitoring Devices

    3) By Lancets: Single-Use Lancets, Multi-Use Lancets

    4) By Test Strips: Standard Test Strips, Smart Test Strips

    5) By Other Product Types: Hemoglobin A1c Testing Kits, Urine Glucose Test Strips, Blood Ketone Meters

    #Diabetes Diagnostics Market Trends Influencing Long-Term Demand

    Leading entities within the diabetes diagnostics sector are prioritizing the creation of novel offerings, including diagnostic solutions for gestational diabetes, with the dual aims of broadening their market presence and addressing the escalating need for prompt identification and care of diabetes occurring during pregnancy. A diagnostic instrument for gestational diabetes is understood as a medical apparatus or examination employed to ascertain and oversee gestational diabetes in expectant mothers, commonly involving the assessment of blood sugar levels, such as through an oral glucose tolerance test (OGTT), to evaluate the body’s sugar metabolism during pregnancy. Illustratively, in August of 2024, DirectSens GmbH, a biotechnology firm situated in Austria, introduced the XpressGT RUO kit, an advanced biosensor device engineered for identifying conditions linked to insulin resistance, encompassing gestational diabetes, endometriosis, and hepatic ailments. This kit delivers swift outcomes by quantifying 2-hydroxybutyrate (2-HB) concentrations in peripheral blood and functions seamlessly with conventional laboratory analysis equipment, heralding a potential for earlier diagnosis and consequently better prognoses for a vast global patient population.

    Diabetes Diagnostics Market Key Companies And Competitive Benchmarking

    Major companies operating in the diabetes diagnostics market are F. Hoffmann-La Roche AG, Bayer AG, Abbott Laboratories, Medtronic plc, DexCom Inc, Tandem Diabetes Care Inc, Ypsomed AG, LifeScan Inc, Nova Biomedical Corporation, Ascensia Diabetes Care Holdings AG, ARKRAY Inc, PTS Diagnostics Inc, AgaMatrix Inc, Senseonics Holdings Inc, DarioHealth Corp, Bionime Corporation, Acon Laboratories Inc, Sinocare Inc, i-SENS Inc, Prodigy Diabetes Care LLC, Rossmax International Ltd, Menarini Diagnostics s.r.l, Trividia Health Inc, EKF Diagnostics Holdings plc.

    Access The Complete Diabetes Diagnostics Market Report:

    https://www.thebusinessresearchcompany.com/report/diabetes-diagnostics-global-market-report

    Diabetes Diagnostics Market Regional Analysis And Leading Geography

    North Americawas the largest region in the diabetes diagnostics market in 2025. The regions covered in the diabetes diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Diabetes Diagnostics Market Outlook (2026–2030): Long-Term Insights

    Diabetes Diagnostics Market Outlook (2026–2030): Long-Term Insights

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    How Large Will The Diabetes Diagnostics Market Be By 2030 Compared To Its 2026 Market Size?

    The diabetes diagnostics market has experienced significant expansion in recent years. Its value is projected to climb from $27.31 billion in 2025 to $29.39 billion in 2026, at a compound annual growth rate (CAGR) of 7.6%. The historical increase can be linked to factors such as the rising incidence of diabetes, continued reliance on fingerstick blood glucose testing, the proliferation of hospital-based diagnostics, greater public awareness of glycemic control, and the expansion of diagnostic laboratories.

    The diabetes diagnostics market is anticipated to show significant expansion over the next few years, with its size projected to reach $38.98 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.3%. This expected growth during the forecast period is attributed to several factors, including the increased use of continuous glucose monitoring, the rising adoption of homecare diagnostics, technological improvements in biosensors, an increase in healthcare expenditure, and the broadening of digital health ecosystems. Notable trends for this period encompass the wider acceptance of continuous glucose monitoring, the integration of intelligent and connected diagnostic devices, a growing demand for home-based diabetes testing, an amplified focus on early diabetes screening programs, and breakthroughs in non-invasive glucose monitoring.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/report/diabetes-diagnostics-global-market-report

    What Significant Factors Are Influencing The Diabetes Diagnostics Market Expansion?

    The increasing incidence of obesity is anticipated to fuel the expansion of the diabetes diagnostics market moving forward. Obesity is defined as an excessive accumulation of body fat that heightens the risk of various health conditions, including heart disease and diabetes. The growing prevalence of obesity is attributed to factors such as sedentary lifestyles, increased consumption of processed and high-calorie foods, genetic predisposition, and limited physical activity. Diabetes diagnostics assist in obesity management by identifying insulin resistance and glucose metabolism issues at an early stage, enabling timely interventions to prevent weight gain and related health complications. For instance, in May 2025, according to the Office for Health Improvement and Disparities, a UK-based government body, from 2023 to 2024, an estimated 64.5% of adults aged 18 and over in England were overweight or living with obesity, up from 64.0% in 2022 to 2023. Consequently, the escalating prevalence of obesity is driving the growth of the diabetes diagnostics market.

    What Are The Key Segment Divisions In The Diabetes Diagnostics Market Segment Structure?

    The diabetes diagnostics market covered in this report is segmented –

    1) By Product Type: Blood Glucose Meters, Continuous Glucose Monitoring Devices, Lancets, Test Strips, Other Product Types

    2) By Diabetes Type: Diabetes I, Diabetes Ii, Gestational Diabetes

    3) By End-User: Hospitals, Diagnostic Centers, Homecare Settings, Other End-Users

    Subsegments:

    1) By Blood Glucose Meters: Traditional Blood Glucose Meters, Smart Blood Glucose Meters, Bluetooth-Enabled Blood Glucose Meters

    2) By Continuous Glucose Monitoring Devices: Wearable CGM Systems, Implantable CGM Systems, Flash Glucose Monitoring Devices

    3) By Lancets: Single-Use Lancets, Multi-Use Lancets

    4) By Test Strips: Standard Test Strips, Smart Test Strips

    5) By Other Product Types: Hemoglobin A1c Testing Kits, Urine Glucose Test Strips, Blood Ketone Meters

    What Trends Are Affecting The Direction Of The Diabetes Diagnostics Market?

    Companies leading the diabetes diagnostics market are focusing on the development of innovative solutions, such as gestational diabetes diagnostics tools, to expand their product portfolios and address the rising demand for early detection and management of diabetes during pregnancy. A gestational diabetes diagnostic tool encompasses medical devices or tests utilized to identify and monitor gestational diabetes in pregnant individuals, typically involving blood glucose testing, like the oral glucose tolerance test (OGTT), to evaluate the body’s sugar processing efficiency throughout pregnancy. As an example, in August 2024, DirectSens GmbH, an Austria-based biotechnology company, introduced its XpressGT RUO kit, a pioneering biosensor tool engineered for the detection of conditions related to insulin resistance, including gestational diabetes, endometriosis, and liver disease. This kit offers rapid results by measuring 2-hydroxybutyrate (2-HB) levels in venous blood and is compatible with standard clinical analyzers. This innovation seeks to provide early diagnostics, potentially improving outcomes for millions of patients globally.

    Which Organizations Are Engaged In The Diabetes Diagnostics Market?

    Major companies operating in the diabetes diagnostics market are F. Hoffmann-La Roche AG, Bayer AG, Abbott Laboratories, Medtronic plc, DexCom Inc, Tandem Diabetes Care Inc, Ypsomed AG, LifeScan Inc, Nova Biomedical Corporation, Ascensia Diabetes Care Holdings AG, ARKRAY Inc, PTS Diagnostics Inc, AgaMatrix Inc, Senseonics Holdings Inc, DarioHealth Corp, Bionime Corporation, Acon Laboratories Inc, Sinocare Inc, i‑SENS Inc, Prodigy Diabetes Care LLC, Rossmax International Ltd, Menarini Diagnostics s.r.l, Trividia Health Inc, EKF Diagnostics Holdings plc.

    Get The Full Diabetes Diagnostics Market Report:

    https://www.thebusinessresearchcompany.com/report/diabetes-diagnostics-global-market-report

    Which Region Accounts For The Largest Portion Of The Diabetes Diagnostics Market?

    North America was the largest region in the diabetes diagnostics market in 2025. The regions covered in the diabetes diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Diabetes Diagnostics Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/diabetes-diagnostics-global-market-report

    Browse Through More Reports Similar to the Global Diabetes Diagnostics Market 2026, By The Business Research Company

    Clinical Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

    Digital Diabetes Management Market Report 2026

    https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report

    Point Of Care Glucose Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • A key trend shaping the Diabetes Diagnostics Market involves the Advancements In Early Detection And Management

    A key trend shaping the Diabetes Diagnostics Market involves the Advancements In Early Detection And Management

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Market Value Is Expected For The Diabetes Diagnostics Market At The End Of The 2026–2030 Forecast Period?

    The diabetes diagnostics market size has demonstrated robust growth in recent years. It is anticipated to increase from $27.31 billion in 2025 to $29.39 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.6%. The expansion witnessed during the historic period can be ascribed to several factors, including the escalating prevalence of diabetes, the continued reliance on fingerstick blood glucose testing, the development of hospital-based diagnostics, heightened awareness of glycemic control, and the proliferation of diagnostic laboratories.

    The diabetes diagnostics market size is projected for robust expansion over the coming years. This market is anticipated to reach $38.98 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.3%. Factors driving this growth during the forecast period include the increased utilization of continuous glucose monitoring, a rise in homecare diagnostics adoption, significant technological progress in biosensors, greater healthcare spending, and the proliferation of digital health ecosystems. Key trends anticipated during this period encompass the wider acceptance of continuous glucose monitoring, the incorporation of smart and interconnected diagnostic tools, growing consumer demand for at-home diabetes testing, an enhanced emphasis on early diabetes screening initiatives, and innovations in non-invasive glucose monitoring methods.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=21167&type=smp

    What Drivers Are Shaping The Future Growth Of The Diabetes Diagnostics Market?

    An increasing rate of obesity is anticipated to boost the expansion of the diabetes diagnostics market in the future. Obesity is characterized by an excessive build-up of body fat, elevating the likelihood of various health issues, including heart disease and diabetes. This elevated prevalence of obesity stems from elements like inactive lifestyles, greater intake of processed and calorie-dense foods, genetic tendencies, and insufficient physical movement. Diabetes diagnostics aid in managing obesity through early detection of insulin resistance and problems with glucose metabolism, thereby facilitating prompt actions to avoid weight gain and associated health complexities. For example, in May 2025, the Office for Health Improvement and Disparities, a UK government body, reported that approximately 64.5% of adults aged 18 and above in England were overweight or obese between 2023 and 2024, an increase from 64.0% in 2022 to 2023. Consequently, the rising incidence of obesity is fueling the expansion of the diabetes diagnostics market.

    What Segment Types Make Up The Diabetes Diagnostics Market?

    The diabetes diagnostics market covered in this report is segmented –

    1) By Product Type: Blood Glucose Meters, Continuous Glucose Monitoring Devices, Lancets, Test Strips, Other Product Types

    2) By Diabetes Type: Diabetes I, Diabetes Ii, Gestational Diabetes

    3) By End-User: Hospitals, Diagnostic Centers, Homecare Settings, Other End-Users

    Subsegments:

    1) By Blood Glucose Meters: Traditional Blood Glucose Meters, Smart Blood Glucose Meters, Bluetooth-Enabled Blood Glucose Meters

    2) By Continuous Glucose Monitoring Devices: Wearable CGM Systems, Implantable CGM Systems, Flash Glucose Monitoring Devices

    3) By Lancets: Single-Use Lancets, Multi-Use Lancets

    4) By Test Strips: Standard Test Strips, Smart Test Strips

    5) By Other Product Types: Hemoglobin A1c Testing Kits, Urine Glucose Test Strips, Blood Ketone Meters

    How Are Trends Transforming The Diabetes Diagnostics Market Landscape?

    Major companies in the diabetes diagnostics market are prioritizing the development of cutting-edge products, such as gestational diabetes diagnostics tools, to expand their offerings and meet the growing demand for early detection and management of diabetes during pregnancy. A gestational diabetes diagnostic tool refers to medical devices or tests utilized to identify and monitor gestational diabetes in pregnant women, typically involving blood glucose testing, like the oral glucose tolerance test (OGTT), to assess the body’s sugar processing efficiency during pregnancy. For instance, in August 2024, DirectSens GmbH, an Austria-based biotechnology company, launched the XpressGT RUO kit, a pioneering biosensor tool designed for detecting insulin resistance-related conditions such as gestational diabetes, endometriosis, and liver disease. This kit provides rapid results by measuring 2-hydroxybutyrate (2-HB) levels in venous blood and is compatible with standard clinical analyzers. This innovation aims to provide early diagnostics, potentially improving outcomes for millions of patients worldwide.

    Who Are The Key Players Driving Competition In The Diabetes Diagnostics Market?

    Major companies operating in the diabetes diagnostics market are F. Hoffmann-La Roche AG, Bayer AG, Abbott Laboratories, Medtronic plc, DexCom Inc, Tandem Diabetes Care Inc, Ypsomed AG, LifeScan Inc, Nova Biomedical Corporation, Ascensia Diabetes Care Holdings AG, ARKRAY Inc, PTS Diagnostics Inc, AgaMatrix Inc, Senseonics Holdings Inc, DarioHealth Corp, Bionime Corporation, Acon Laboratories Inc, Sinocare Inc, i‑SENS Inc, Prodigy Diabetes Care LLC, Rossmax International Ltd, Menarini Diagnostics s.r.l, Trividia Health Inc, EKF Diagnostics Holdings plc.

    Read the full diabetes diagnostics market report here:

    https://www.thebusinessresearchcompany.com/report/diabetes-diagnostics-global-market-report

    Which Geographic Regions Are Influencing Demand In The Diabetes Diagnostics Market?

    North America was the largest region in the diabetes diagnostics market in 2025. The regions covered in the diabetes diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Diabetes Diagnostics Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=21167&type=smp

    Browse Through More Reports Similar to the Global Diabetes Diagnostics Market 2026, By The Business Research Company

    Digital Diabetes Management Global Market Report

    https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report

    Point Of Care Glucose Testing Global Market Report

    https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report

    Clinical Diagnostics Global Market Report

    https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Diabetes Diagnostics Market Forecast 2026: Where the Industry Is Headed

    Diabetes Diagnostics Market Forecast 2026: Where the Industry Is Headed

    Uncover key drivers, emerging technologies, and competitive movements shaping the diabetes diagnostics market from 2026–2035 with trusted insights from The Business Research Company

    What are the forecasted starting (2026) and ending (2030) market sizes for the Diabetes Diagnostics Market?

    The diabetes diagnostics market has demonstrated robust growth in recent years. It is projected to increase from $27.31 billion in 2025 to $29.39 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.6%. The expansion observed historically can be attributed to factors such as the rising incidence of diabetes, the widespread use of fingerstick blood glucose testing, the development of hospital-based diagnostic services, enhanced awareness regarding glycemic control, and the growth in diagnostic laboratories.

    The diabetes diagnostics market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $38.98 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.3%. This projected growth during the forecast period can be attributed to factors such as the increased utilization of continuous glucose monitoring, the growing acceptance of homecare diagnostic solutions, advancements in biosensor technology, a rise in healthcare spending, and the expansion of digital health ecosystems. Key trends expected during this period involve the broader adoption of continuous glucose monitoring, the incorporation of smart and interconnected diagnostic instruments, a heightened demand for at-home diabetes testing, an amplified emphasis on early diabetes screening initiatives, and progress in non-invasive glucose monitoring methods.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=21167&type=smp

    What Drivers Are Supporting Technological Adoption In The Diabetes Diagnostics Market?

    The rising incidence of obesity is projected to fuel the expansion of the diabetes diagnostics market in the future. Obesity is characterized by an excessive accumulation of body fat, which elevates the risk of various health problems, including heart disease and diabetes. The increased occurrence of obesity is linked to factors such as inactive lifestyles, higher consumption of processed and calorie-dense foods, genetic predispositions, and inadequate physical activity. Diabetes diagnostics assist in obesity management by enabling early identification of insulin resistance and issues with glucose metabolism, thereby allowing for timely interventions to prevent further weight gain and related health complications. For example, in May 2025, the Office for Health Improvement and Disparities, a UK-based government body, reported that an estimated 64.5% of adults aged 18 and over in England were overweight or living with obesity from 2023 to 2024, representing an increase from 64.0% in 2022 to 2023. Thus, the increasing prevalence of obesity is propelling the growth of the diabetes diagnostics market.

    What Segment Types Are Examined In The Diabetes Diagnostics Market?

    The diabetes diagnostics market covered in this report is segmented –

    1) By Product Type: Blood Glucose Meters, Continuous Glucose Monitoring Devices, Lancets, Test Strips, Other Product Types

    2) By Diabetes Type: Diabetes I, Diabetes Ii, Gestational Diabetes

    3) By End-User: Hospitals, Diagnostic Centers, Homecare Settings, Other End-Users

    Subsegments:

    1) By Blood Glucose Meters: Traditional Blood Glucose Meters, Smart Blood Glucose Meters, Bluetooth-Enabled Blood Glucose Meters

    2) By Continuous Glucose Monitoring Devices: Wearable CGM Systems, Implantable CGM Systems, Flash Glucose Monitoring Devices

    3) By Lancets: Single-Use Lancets, Multi-Use Lancets

    4) By Test Strips: Standard Test Strips, Smart Test Strips

    5) By Other Product Types: Hemoglobin A1c Testing Kits, Urine Glucose Test Strips, Blood Ketone Meters

    Which Trends Are Expected To Influence The Diabetes Diagnostics Market In The Upcoming Years?

    Leading firms within the diabetes diagnostics sector are concentrating on creating advanced offerings like gestational diabetes diagnostics tools. This strategy aims to broaden their product range and address the increasing need for prompt diagnosis and intervention for diabetes during pregnancy. A gestational diabetes diagnostic tool encompasses medical equipment or examinations employed to identify and track gestational diabetes in expectant mothers. These often include blood glucose tests, such as the oral glucose tolerance test (OGTT), which evaluate the body’s sugar processing efficiency during gestation. As an illustration, in August 2024, DirectSens GmbH, an Austria-based biotechnology company, introduced the XpressGT RUO kit. This innovative biosensor tool is engineered to detect conditions linked to insulin resistance, including gestational diabetes, endometriosis, and liver disease. The kit offers quick results by measuring 2-hydroxybutyrate (2-HB) levels in venous blood and is compatible with existing clinical analyzers. This advancement seeks to provide early diagnostic capabilities, potentially enhancing the prognosis for millions of individuals globally.

    Who Are The Primary Competitors In The Global Diabetes Diagnostics Market?

    Major companies operating in the diabetes diagnostics market are F. Hoffmann-La Roche AG, Bayer AG, Abbott Laboratories, Medtronic plc, DexCom Inc, Tandem Diabetes Care Inc, Ypsomed AG, LifeScan Inc, Nova Biomedical Corporation, Ascensia Diabetes Care Holdings AG, ARKRAY Inc, PTS Diagnostics Inc, AgaMatrix Inc, Senseonics Holdings Inc, DarioHealth Corp, Bionime Corporation, Acon Laboratories Inc, Sinocare Inc, i-SENS Inc, Prodigy Diabetes Care LLC, Rossmax International Ltd, Menarini Diagnostics s.r.l, Trividia Health Inc, EKF Diagnostics Holdings plc.

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/diabetes-diagnostics-global-market-report

    Which Global Regions Are Shaping The Competitive Landscape Of The Diabetes Diagnostics Market?

    North America was the largest region in the diabetes diagnostics market in 2025. The regions covered in the diabetes diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Diabetes Diagnostics Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=21167&type=smp

    Browse Through More Reports Similar to the Global Diabetes Diagnostics Market 2026, By The Business Research Company

    Clinical Diagnostics Market Report 2026

    https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

    Digital Diabetes Management Market Report 2026

    https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report

    Point Of Care Glucose Testing Market Report 2026

    https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • How Will The Diabetes Diagnostics Market Expand At A CAGR Of 7.5% Through 2029?

    How Will The Diabetes Diagnostics Market Expand At A CAGR Of 7.5% Through 2029?

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    How Big Is The Diabetes Diagnostics Market Today And What Is Its Future Size?

    The market size for diabetes diagnostics has seen robust growth in the last few years. It’s projected that it will expand from $25.39 billion in 2024 to $27.31 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.6%. The past growth has been a result of the increasing occurrence of diabetes, a growing elderly population, the rise in sedentary lifestyles, an increased willingness to adopt minimally invasive diagnostics, and the rising prevalence of obesity.

    In the coming years, the diabetes diagnostics market is anticipated to experience significant growth, reaching $36.42 billion in 2029 with a compound annual growth rate (CAGR) of 7.5%. This growth during the estimated period can be ascribed to the growing use of insulin pumps, the escalation in diabetes-related technological advancements, an increase in unhealthy lifestyle adoption, a rise in the incidence of type 1 and type 2 diabetes, and the expansion of healthcare infrastructure. Key trends expected throughout this period include advancements in biosensor technology, technological progress, improvements in diagnostic technologies, personalized medicine and targeted therapies, as well as advanced technologies in in vitro diagnostic products.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=21167&type=smp

    What External And Internal Drivers Are Influencing The Diabetes Diagnostics Market?

    The escalating rates of obesity are predicted to stimulate the expansion of the diabetes diagnostics market. Defined as the excessive buildup of body fat, obesity enhances the likelihood of numerous health issues, including heart disease and diabetes. The increased occurrence of obesity is ascribed to aspects such as static lifestyles, rising intake of processed and high-calorie foods, genetic factors, and insufficient physical activity. Diabetes diagnostics aid in managing obesity by recognizing insulin resistance and glucose metabolism problems at an early stage, thereby allowing for prompt actions to avert weight gain and associated health issues. For instance, the Centers for Disease Control and Prevention, a government agency based in the US, stated in September 2023 that the obesity rate among adults in 22 states was 35% or more in 2022, a rise from 19 states in 2021. Consequently, the escalating prevalence of obesity is fuelling the progression of the diabetes diagnostics market.

    How Is The Diabetes Diagnostics Market Categorized Across Applications And Types?

    The diabetes diagnosticsmarket covered in this report is segmented –

    1) By Product Type: Blood Glucose Meters; Continuous Glucose Monitoring Devices; Lancets; Test Strips; Other Product Types

    2) By Diabetes Type: Diabetes I; Diabetes II; Gestational Diabetes

    3) By End-User: Hospitals; Diagnostic Centers; Homecare Settings; Other End-Users

    Subsegments:

    1) By Blood Glucose Meters: Traditional Blood Glucose Meters; Smart Blood Glucose Meters; Bluetooth-enabled Blood Glucose Meters

    2) By Continuous Glucose Monitoring Devices: Wearable CGM Systems; Implantable CGM Systems; Flash Glucose Monitoring Devices

    3) By Lancets: Single-use Lancets; Multi-use Lancets

    4) By Test Strips: Standard Test Strips; Smart Test Strips

    5) By Other Product Types: Hemoglobin A1c Testing Kits; Urine Glucose Test Strips; Blood Ketone Meters

    How Are Market Trends Influencing Competition In The Diabetes Diagnostics Market?

    Major companies in the diabetes diagnostics market are prioritizing the development of advanced solutions, including gestational diabetes diagnostic tools, to broaden their offerings and meet the increasing need for early pregnancy-related diabetes detection. These tools often include tests like the OGTT to monitor blood glucose levels in expecting mothers. For instance, in August 2024, Austria-based DirectSens GmbH released the XpressGT RUO kit—a new biosensor for detecting insulin resistance-related conditions such as gestational diabetes, endometriosis, and liver disease. The kit delivers rapid results by measuring 2-HB levels in venous blood and works with standard clinical analyzers, aiming to boost early detection and improve patient care globally.

    Who Are The Global Leaders Steering The Diabetes Diagnostics Market Forward?

    Major companies operating in the diabetes diagnostics market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Novartis AG, 3M Company, Medtronic plc, Regeneron Pharmaceuticals Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, DexCom Inc, Santen Pharmaceutical Co. Ltd., Topcon Corporation, Tandem Diabetes Care Inc, Ypsomed AG, LifeScan Inc, Nova Biomedical Corporation, Ascensia Diabetes Care Holdings AG, ARKRAY Inc, Optos plc, Bioland Technology Ltd, PTS Diagnostics Inc, AgaMatrix Inc, Senseonics Holdings Inc, DarioHealth Corp.

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/diabetes-diagnostics-global-market-report

    What Are The Emerging Regional Trends Driving The Diabetes Diagnostics Market?

    North America was the largest region in the diabetes diagnostics market in 2024. The regions covered in the diabetes diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=21167&type=smp

    Browse Through More Reports Similar to the Global Diabetes Diagnostics Market 2025, By The Business Research Company

    Digital Diabetes Management Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report

    Diabetes Care Devices Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-global-market-report

    Artificial Intelligence In Diabetes Management Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-diabetes-management-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Diabetes Diagnostics Market Expansion Outlook: $36.42 Billion by 2029 Forecast

    Diabetes Diagnostics Market Expansion Outlook: $36.42 Billion by 2029 Forecast

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    What Are The Forecasted Market Size Estimates For The Diabetes Diagnostics Market Between 2025 And 2029?

    The diabetes diagnostics market size has exhibited robust growth in recent years. It is anticipated to increase from $25.39 billion in 2024 to $27.31 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.6%. The expansion observed in past periods can be credited to factors such as the rising prevalence of diabetes, an expanding geriatric population, an increase in sedentary lifestyles, the growing adoption of minimally invasive diagnostic methods, and a rising prevalence of obesity.

    The diabetes diagnostics market is anticipated to experience substantial expansion in the coming years. By 2029, its valuation is projected to reach $36.42 billion, achieving a compound annual growth rate (CAGR) of 7.5%. This projected growth is driven by several factors, including the increasing use of insulin pumps, continuous innovation in diabetes technology, a rise in unhealthy lifestyles, the escalating incidence of type 1 and type 2 diabetes, and the development of healthcare infrastructure. Key developments during this period are expected to involve progress in biosensor technology, broader technological innovations, improvements in diagnostic methods, the emergence of personalized medicine and targeted therapies, and sophisticated advancements in in vitro diagnostic products.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=21167&type=smp

    What Are The Top Growth Drivers Impacting The Diabetes Diagnostics Market Outlook?

    The increasing incidence of obesity is projected to boost the expansion of the diabetes diagnostics market. Obesity is characterized by an excessive build-up of body fat, elevating the likelihood of various medical issues like heart disease and diabetes. The rising rates of obesity are linked to factors such as inactive lifestyles, greater intake of processed and high-calorie foods, genetic factors, and insufficient physical activity. Diabetes diagnostics play a crucial role in managing obesity by detecting early signs of insulin resistance and glucose metabolism problems, allowing for prompt actions to avert further weight gain and associated health complications. For example, in September 2023, the Centers for Disease Control and Prevention, a US-based government agency, reported that in 2022, 22 states recorded an adult obesity rate of 35% or higher, up from 19 states in 2021. Consequently, the widespread prevalence of obesity is stimulating the growth of the diabetes diagnostics market.

    What Are The Different Segment Classifications Within The Diabetes Diagnostics Market?

    The diabetes diagnosticsmarket covered in this report is segmented –

    1) By Product Type: Blood Glucose Meters; Continuous Glucose Monitoring Devices; Lancets; Test Strips; Other Product Types

    2) By Diabetes Type: Diabetes I; Diabetes II; Gestational Diabetes

    3) By End-User: Hospitals; Diagnostic Centers; Homecare Settings; Other End-Users

    Subsegments:

    1) By Blood Glucose Meters: Traditional Blood Glucose Meters; Smart Blood Glucose Meters; Bluetooth-enabled Blood Glucose Meters

    2) By Continuous Glucose Monitoring Devices: Wearable CGM Systems; Implantable CGM Systems; Flash Glucose Monitoring Devices

    3) By Lancets: Single-use Lancets; Multi-use Lancets

    4) By Test Strips: Standard Test Strips; Smart Test Strips

    5) By Other Product Types: Hemoglobin A1c Testing Kits; Urine Glucose Test Strips; Blood Ketone Meters

    What Long-Term Trends Will Shape The Future Growth Of The Diabetes Diagnostics Industry?

    Leading companies in the diabetes diagnostics sector are focusing on the development of innovative products, such as gestational diabetes diagnostics tools, to expand their offerings and address the increasing demand for early detection and management of diabetes during pregnancy. A gestational diabetes diagnostic tool refers to medical devices or tests employed to identify and monitor gestational diabetes in expectant mothers, typically involving blood glucose testing, like the oral glucose tolerance test (OGTT), to assess how efficiently the body processes sugar throughout gestation. For instance, in August 2024, DirectSens GmbH, an Austria-based biotechnology company, introduced the XpressGT RUO kit, a pioneering biosensor tool designed for detecting insulin resistance-related conditions such as gestational diabetes, endometriosis, and liver disease. This kit offers rapid results by measuring 2-hydroxybutyrate (2-HB) levels in venous blood and is compatible with standard clinical analyzers. This innovation aims to provide early diagnostics, with the potential to improve outcomes for millions of patients globally.

    Which Leading Companies Dominate The Diabetes Diagnostics Market Share?

    Major companies operating in the diabetes diagnostics market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Novartis AG, 3M Company, Medtronic plc, Regeneron Pharmaceuticals Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, DexCom Inc, Santen Pharmaceutical Co. Ltd., Topcon Corporation, Tandem Diabetes Care Inc, Ypsomed AG, LifeScan Inc, Nova Biomedical Corporation, Ascensia Diabetes Care Holdings AG, ARKRAY Inc, Optos plc, Bioland Technology Ltd, PTS Diagnostics Inc, AgaMatrix Inc, Senseonics Holdings Inc, DarioHealth Corp.

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/diabetes-diagnostics-global-market-report

    Which Region Shows The Highest Potential For Future Expansion In The Diabetes Diagnostics Market?

    North America was the largest region in the diabetes diagnostics market in 2024. The regions covered in the diabetes diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Version Of The Diabetes Diagnostics Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=21167&type=smp

    Browse Through More Reports Similar to the Global Diabetes Diagnostics Market 2025, By The Business Research Company

    Digital Diabetes Management Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report

    Diabetes Care Devices Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-global-market-report

    Artificial Intelligence In Diabetes Management Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-diabetes-management-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • $36.42 Billion Forecast for Diabetes Diagnostics Market by 2029, Backed by Demand and Innovation

    $36.42 Billion Forecast for Diabetes Diagnostics Market by 2029, Backed by Demand and Innovation

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What is the Projected CAGR for the Diabetes Diagnostics Market Size from 2025 to 2034?

    The size of the diabetes diagnostics market has significantly expanded in the past years. The market is estimated to rise from $25.39 billion in 2024 to $27.31 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.6%. The historical growth is linked to several factors such as the increasing cases of diabetes, growing elderly population, surge in sedentary lifestyles, greater preference for minimally invasive diagnostic techniques, and the rising prevalence of obesity.

    In the coming years, the market size for diabetes diagnostics is predicted to experience significant expansion. The projection sees it escalating to a worth of $36.42 billion in 2029, progressing at a CAGR of 7.5%. Contributing to this predicted growth, during the forecast period, are factors such as the increased use of insulin pumps, numerous developments in diabetes technologies, a rise in unhealthy lifestyles, a surge in incidences of type 1 and type 2 diabetes, and the growth of the healthcare infrastructure. Expected market trends for the period include progress in biosensor technology, technological advancements, developments in diagnostic technologies, personalized medical treatments, targeted therapies, and progressive technologies in in vitro diagnostic products.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=21167&type=smp

    What Are the Core Growth Drivers Propelling the Diabetes Diagnostics Market Forward?

    The rise in obesity rates is predicted to fuel advances in the diabetes diagnostics market. Obesity, characterized by an excessive buildup of body fat, elevates the risk of numerous health issues, including heart diseases and diabetes. Such a widespread presence of obesity can be accredited to a combination of factors such as sedentary lifestyles, an increased intake of processed and high-calorie foods, genetic susceptibility, and lack of physical exercise. Diabetes diagnostics play a critical role in arresting obesity progression by detecting early signs of insulin resistance and problems with glucose metabolism, allowing for prompt intervention to prevent weight escalation and related health risks. Take for example, data from the Centers for Disease Control and Prevention, a government agency based out of the US, that reveals an increase in adult obesity rate – in September 2023, 22 states were found to have an adult obesity rate of 35% or higher, up from 19 states in 2021. This rising incidence of obesity thus forms the basis of expansion for the diabetes diagnostics market.

    What Segment Types Define the Diabetes Diagnostics Market Structure?

    The diabetes diagnosticsmarket covered in this report is segmented –

    1) By Product Type: Blood Glucose Meters; Continuous Glucose Monitoring Devices; Lancets; Test Strips; Other Product Types

    2) By Diabetes Type: Diabetes I; Diabetes II; Gestational Diabetes

    3) By End-User: Hospitals; Diagnostic Centers; Homecare Settings; Other End-Users

    Subsegments:

    1) By Blood Glucose Meters: Traditional Blood Glucose Meters; Smart Blood Glucose Meters; Bluetooth-enabled Blood Glucose Meters

    2) By Continuous Glucose Monitoring Devices: Wearable CGM Systems; Implantable CGM Systems; Flash Glucose Monitoring Devices

    3) By Lancets: Single-use Lancets; Multi-use Lancets

    4) By Test Strips: Standard Test Strips; Smart Test Strips

    5) By Other Product Types: Hemoglobin A1c Testing Kits; Urine Glucose Test Strips; Blood Ketone Meters

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=21167&type=smp

    Which Geographic Areas Hold the Strongest Growth Potential in the Diabetes Diagnostics Market?

    North America was the largest region in the diabetes diagnostics market in 2024. The regions covered in the diabetes diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Which Emerging Trends that Are Influencing theDiabetes Diagnostics Industry Evolution?

    Key companies in the diabetes diagnostics market are concentrating on creating novel products, including tools for diagnosing gestational diabetes, to broaden their product range and meet increasing demand for early diagnosis and management of diabetes in pregnancy. These diagnostic tools for gestational diabetes typically involve blood glucose tests such as the oral glucose tolerance test (OGTT), geared towards monitoring how a woman’s body handles sugar during pregnancy. For example, an Austria-based biotech firm, DirectSens GmbH, released an innovative biosensor instrument, the XpressGT RUO kit, in August 2024. It is designed for detecting conditions related to insulin resistance like gestational diabetes, endometriosis, and liver disease. The kit quicky measures 2-hydroxybutyrate (2-HB) levels in venous blood and can be used with standard clinical analyzers. The objective behind this revolutionary product is to present early detection solutions, potentially enhancing the health outcomes for patients on a global scale.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/diabetes-diagnostics-global-market-report

    What Is the Definition of the Diabetes Diagnostics Market?

    Diabetes diagnostics refers to the methods and tests used to identify and monitor diabetes by measuring blood glucose levels and other relevant biomarkers. It involves various medical assessments to detect abnormal glucose metabolism and assess the risk or presence of diabetes. Accurate diagnostics aid in early detection, disease management, and treatment planning.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21167

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Diabetes Diagnostics Industry Valued at $36.71 Billion by 2029 With CAGR of 7.6% | Size and Share Insights

    Diabetes Diagnostics Industry Valued at $36.71 Billion by 2029 With CAGR of 7.6% | Size and Share Insights

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Is the Forecast for the Diabetes Diagnostics Market from 2024 to 2025?

    The market for diabetes diagnostics has seen robust growth in the recent past. It is projected to expand from $25.39 billion in 2024 to $27.39 billion in 2025, growing at a compound annual growth rate (CAGR) of 7.9%. Factors such as an increase in diabetes cases, a growing elderly population, a rise in sedentary behaviors, escalated use of less invasive diagnostic procedures, and an uptick in obesity rates have all contributed to the growth witnessed during the historic period.

    What Is the Projected Market Size of the Diabetes Diagnostics Market?

    The market size of diabetes diagnostics is predicted to witness robust growth in the coming years, reaching a valuation of $36.72 billion by 2029, accelerating at a Compound Annual Growth Rate (CAGR) of 7.6%. The progression in the prediction period can be associated with numerous factors including the increased usage of insulin pumps, advancements in diabetes-related technology, adoption of unhealthy lifestyle habits, heightening instances of type 1 and type 2 diabetes, and a growing healthcare infrastructure. Major trends expected during the forecast period encompass improvements in biosensor technology, technological advancements, developments in diagnostic technologies, the rise of personalized medicine and targeted therapies, and the introduction of advanced technologies in in vitro diagnostic products.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=21167&type=smp

    Who are the Major Competitors in the Diabetes Diagnostics Market Outlook?

    Major companies operating in the diabetes diagnostics market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Novartis AG, 3M Company, Medtronic plc, Regeneron Pharmaceuticals Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, DexCom Inc, Santen Pharmaceutical Co. Ltd., Topcon Corporation, Tandem Diabetes Care Inc, Ypsomed AG, LifeScan Inc, Nova Biomedical Corporation, Ascensia Diabetes Care Holdings AG, ARKRAY Inc, Optos plc, Bioland Technology Ltd, PTS Diagnostics Inc, AgaMatrix Inc, Senseonics Holdings Inc, DarioHealth Corp.

    What Is Fueling Growth in the Diabetes Diagnostics Market?

    The rise in obesity rates is anticipated to accelerate the expansion of the diabetes diagnostics market. Obesity is characterized by the excessive accumulation of body fat, which poses a higher risk of various diseases, including diabetes and heart disease. The surge in obesity prevalence can be linked to sedentary lifestyles, high intake of processed and calorie-dense foods, genetic factors, and lack of physical activity. Diabetes diagnostics aid in managing obesity, detecting issues such as insulin resistance and glucose metabolism problems at an early stage and allowing for prompt interventions to avoid weight gain and associated health risks. For instance, the Centers for Disease Control and Prevention, a US government agency, reported in September 2023 that in 2022, the adult obesity rate was 35% or greater in 22 states, up from 19 states in 2021. Hence, the growing prevalence of obesity constitutes a major factor propelling the growth of the diabetes diagnostics market.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=21167&type=smp

    Which Diabetes Diagnostics Market Segments Are Growing the Fastest?

    The diabetes diagnostics market covered in this report is segmented –

    1) By Product Type: Blood Glucose Meters, Continuous Glucose Monitoring Devices, Lancets, Test Strips, Other Product Types

    2) By Diabetes Type: Diabetes I, Diabetes II, Gestational Diabetes

    3) By End-User: Hospitals, Diagnostic Centers, Homecare Settings, Other End-Users

    Subsegments:

    1) By Blood Glucose Meters: Traditional Blood Glucose Meters, Smart Blood Glucose Meters, Bluetooth-enabled Blood Glucose Meters

    2) By Continuous Glucose Monitoring Devices: Wearable CGM Systems, Implantable CGM Systems, Flash Glucose Monitoring Devices

    3) By Lancets: Single-use Lancets, Multi-use Lancets

    4) By Test Strips: Standard Test Strips, Smart Test Strips

    5) By Other Product Types: Hemoglobin A1c Testing Kits, Urine Glucose Test Strips, Blood Ketone Meters

    Which Industry Trends Are Shaping the Future of the Diabetes Diagnostics Market?

    Key businesses in the diabetes diagnostics industry are concentrating their efforts on creating novel products, such as tools for diagnosing gestational diabetes, in an attempt to broaden their product range and meet the rising need for early detection and management of diabetes during pregnancy. Medically, a gestational diabetes diagnostic tool pertains to medical instruments or tests used for identifying and tracking gestational diabetes in expectant mothers. This often incorporates blood glucose testing methods like the oral glucose tolerance test (OGTT) to evaluate how well their body manages sugar during gestation. For instance, Austria’s biotech firm DirectSens GmbH, released an innovative biosensor apparatus called the XpressGT RUO kit, in August 2024. This product has been created for identifying insulin resistance-related issues such as gestational diabetes, endometriosis, and liver disease. The kit facilitates swift results by measuring 2-hydroxybutyrate (2-HB) levels in the blood from veins, and it can be used with ordinary clinical analyzers. The objective of this innovative solution is to facilitate early diagnosis, with the potential to enhance the health outcomes for millions of patients across the globe.

    Access The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/diabetes-diagnostics-global-market-report

    Which Countries Are Leading the Diabetes Diagnostics Market?

    North America was the largest region in the diabetes diagnostics market in 2024. The regions covered in the diabetes diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Purchase The Full Report Today:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21167

    This Report Delivers Insight On:

    1. How big is the diabetes diagnostics market, and how is it changing globally?

    2. Who are the major companies in the diabetes diagnostics market, and how are they performing?

    3. What are the key opportunities and risks in the diabetes diagnostics market right now?

    4. Which products or customer segments are growing the most in the diabetes diagnostics market?

    5. What factors are helping or slowing down the growth of the diabetes diagnostics market?

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 2071930708

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Diabetes Diagnostics Market Forecast Reaching $36.72 Billion by 2029 at 7.6% CAGR

    Diabetes Diagnostics Market Forecast Reaching $36.72 Billion by 2029 at 7.6% CAGR

    Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

    How Has The Diabetes Diagnostics Market Size Shifted, And What Is the Outlook Through 2034?

    The market size for diabetes diagnostics has seen a robust growth in the past few years. This is projected to grow from a value of $25.39 billion in 2024 to about $27.39 billion in 2025 with a compound annual growth rate (CAGR) of 7.9%. Factors contributing to this growth during the historic period include an increased occurrence of diabetes, growth in the elderly population, a rise in sedentary lifestyles, a surge in the uptake of minimally invasive diagnostics, and an increasing prevalence of obesity.

    The market size for diabetes diagnostics is poised for robust expansion in the coming years, anticipated to reach $36.72 billion by 2029, with a CAGR of 7.6%. Several factors could drive this growth during the projected period, such as the increasing use of insulin pumps, advancements in diabetes-related technology, unhealthy lifestyle choices on the rise, and a surge in both type 1 and type 2 diabetes incidents. There’s also the aspect of expanding healthcare infrastructure. The forecast period is expected to see significant trends like progress in biosensor technology, technological advancements overall, improved diagnostic technologies, personalized medicine and targeted therapies, as well as refined technologies in in vitro diagnostic products.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=21167&type=smp

    Which Major Market Drivers Are Expected to Boost the Growth Potential of the Diabetes Diagnostics Market?

    The escalation in obesity rates is anticipated to spur the expansion of the diabetes diagnostics market. Obesity, defined as the excessive buildup of body fat, elevates the likelihood of several health issues, including heart disease and diabetes. The surge in obesity rates can be linked to factors like inactive lifestyles, higher intake of processed and calorie-rich foods, genetic factors, and lack of physical exercise. Diabetes diagnostics aid in managing obesity by detecting early signs of insulin resistance and glucose metabolic problems, which allows for prompt actions to prevent weight gain and associated health risks. For example, data from the Centers for Disease Control and Prevention, a US government agency, in September 2023 highlighted that in 2022, 22 states had an adult obesity prevalence of 35% or more, rising from 19 states the previous year. Hence, the escalating rates of obesity are fueling the growth of the diabetes diagnostics market.

    Which Key Market Segments Comprise the Diabetes Diagnostics Market and Drive Its Revenue Growth?

    The diabetes diagnostics market covered in this report is segmented –

    1) By Product Type: Blood Glucose Meters, Continuous Glucose Monitoring Devices, Lancets, Test Strips, Other Product Types

    2) By Diabetes Type: Diabetes I, Diabetes II, Gestational Diabetes

    3) By End-User: Hospitals, Diagnostic Centers, Homecare Settings, Other End-Users

    Subsegments:

    1) By Blood Glucose Meters: Traditional Blood Glucose Meters, Smart Blood Glucose Meters, Bluetooth-enabled Blood Glucose Meters

    2) By Continuous Glucose Monitoring Devices: Wearable CGM Systems, Implantable CGM Systems, Flash Glucose Monitoring Devices

    3) By Lancets: Single-use Lancets, Multi-use Lancets

    4) By Test Strips: Standard Test Strips, Smart Test Strips

    5) By Other Product Types: Hemoglobin A1c Testing Kits, Urine Glucose Test Strips, Blood Ketone Meters

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=21167&type=smp

    Which Areas Are Leading Regions in the Diabetes Diagnostics Market Expansion Across the Globe?

    North America was the largest region in the diabetes diagnostics market in 2024. The regions covered in the diabetes diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Are the Key Market Trends in theDiabetes Diagnostics Market Over the Coming Years?

    Key businesses in the diabetes diagnostics market are striving to innovate, focusing on the creation of advanced products like gestational diabetes diagnostic equipment. This pushes their product range to cover the burgeoning need for earlier detection and management of diabetes during pregnancy. Gestational diabetes diagnostic tools refer to medical tests or devices that monitor and detect gestational diabetes – diabetes developing during pregnancy, usually employing blood sugar tests like the oral glucose tolerance test (OGTT) to measure sugar processing efficiency during pregnancy. For example, in August 2024, an innovative biosensor tool called XpressGT RUO kit was launched for detecting insulin-resistant conditions like gestational diabetes, endometriosis, and liver disease by DirectSens GmbH, a biotechnological company based in Austria. The kit gives rapid results by measuring 2-hydroxybutyrate (2-HB) levels in venous blood and is compatible with typical clinical analysers. This creative solution aims to provide earlier diagnosis, potentially improving the results for millions of patients across the globe.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/diabetes-diagnostics-global-market-report

    How Is the Diabetes Diagnostics Market Conceptually Defined?

    Diabetes diagnostics refers to the methods and tests used to identify and monitor diabetes by measuring blood glucose levels and other relevant biomarkers. It involves various medical assessments to detect abnormal glucose metabolism and assess the risk or presence of diabetes. Accurate diagnostics aid in early detection, disease management, and treatment planning.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21167

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Key Insights into the Diabetes Diagnostics Market: Trends, Growth Rate, and Opportunities Through 2034

    Key Insights into the Diabetes Diagnostics Market: Trends, Growth Rate, and Opportunities Through 2034

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    Which Major Market Drivers Are Expected to Boost the Growth Potential of the Diabetes Diagnostics Market?

    The higher prevalence of obesity is expected to propel the growth of the diabetes diagnostics market. Obesity, which is becoming more widespread due to sedentary lifestyles and unhealthy diets, significantly increases the risk of developing diabetes, particularly type 2 diabetes. Early diabetes diagnostics can help identify insulin resistance and glucose metabolism issues, allowing for timely interventions that manage obesity-related health risks. In September 2023, the Centers for Disease Control and Prevention (CDC) reported that 22 U.S. states had an adult obesity rate of 35% or higher, contributing to an increasing demand for diabetes diagnostics to address these concerns.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=21167&type=smp

    #What Long-Term Growth Rate is Expected for theDiabetes Diagnostics Market Between 2025 and 2034?

    The diabetes diagnostics market has experienced strong growth in recent years, expanding from $25.39 billion in 2024 to $27.39 billion in 2025 at a CAGR of 7.9%. The historical growth can be attributed to the rising prevalence of diabetes, an expanding geriatric population, an increase in sedentary lifestyles, higher adoption of minimally invasive diagnostics, and a growing obesity rate.

    The diabetes diagnostics market is projected to grow substantially, reaching $36.72 billion by 2029 at a CAGR of 7.6%. Growth factors include increased adoption of insulin pumps, technological advancements in diabetes care, unhealthy lifestyle trends, the rising prevalence of type 1 and type 2 diabetes, and improvements in healthcare infrastructure. Major trends include progress in biosensor technology, enhanced diagnostic techniques, personalized medicine and targeted therapies, and innovations in in vitro diagnostic solutions.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21167

    What Are the Key Market Innovations in theDiabetes Diagnostics Market Over the Coming Years?

    In the diabetes diagnostics market, companies are advancing diagnostic tools, such as gestational diabetes diagnostics, to enhance early detection and management during pregnancy. For instance, in August 2024, DirectSens GmbH, an Austria-based biotechnology company, launched the XpressGT RUO kit, a biosensor tool designed to detect insulin resistance-related conditions, including gestational diabetes, endometriosis, and liver disease. The kit provides rapid results by measuring 2-hydroxybutyrate (2-HB) levels in venous blood, offering a non-invasive, fast diagnostic approach compatible with standard clinical analyzers.

    Who Are the Top Companies Driving Innovation and Growth in theDiabetes Diagnostics Market?

    Major companies operating in the diabetes diagnostics market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Novartis AG, 3M Company, Medtronic plc, Regeneron Pharmaceuticals Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, DexCom Inc, Santen Pharmaceutical Co. Ltd., Topcon Corporation, Tandem Diabetes Care Inc, Ypsomed AG, LifeScan Inc, Nova Biomedical Corporation, Ascensia Diabetes Care Holdings AG, ARKRAY Inc, Optos plc, Bioland Technology Ltd, PTS Diagnostics Inc, AgaMatrix Inc, Senseonics Holdings Inc, DarioHealth Corp.

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/diabetes-diagnostics-global-market-report

    Which Key Market Segments Comprise the Diabetes Diagnostics Market and Drive Its Revenue Growth?

    The diabetes diagnostics market covered in this report is segmented –

    1) By Product Type: Blood Glucose Meters, Continuous Glucose Monitoring Devices, Lancets, Test Strips, Other Product Types

    2) By Diabetes Type: Diabetes I, Diabetes II, Gestational Diabetes

    3) By End-User: Hospitals, Diagnostic Centers, Homecare Settings, Other End-Users

    Subsegments:

    1) By Blood Glucose Meters: Traditional Blood Glucose Meters, Smart Blood Glucose Meters, Bluetooth-enabled Blood Glucose Meters

    2) By Continuous Glucose Monitoring Devices: Wearable CGM Systems, Implantable CGM Systems, Flash Glucose Monitoring Devices

    3) By Lancets: Single-use Lancets, Multi-use Lancets

    4) By Test Strips: Standard Test Strips, Smart Test Strips

    5) By Other Product Types: Hemoglobin A1c Testing Kits, Urine Glucose Test Strips, Blood Ketone Meters

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=21167&type=smp

    Which Regions Are Emerging as Leaders in the Diabetes Diagnostics Market?

    North America was the largest region in the diabetes diagnostics market in 2024. The regions covered in the diabetes diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Reports Similar to the Global Diabetes Diagnostics Market 2025, By The Business Research Company:

    Pertussis Vaccine Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

    Influenza A Virus Vaccine Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/h1n1-vaccine-global-market-report

    Weight Loss Supplements Global Market Report 2025

    https://thebusinessresearchcompany.com/report/weight-loss-supplements-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: